Fig. 2From: Seasonal clustering of sinopulmonary mucormycosis in patients with hematologic malignancies at a large comprehensive cancer centerPosaconazole use (prophylaxis and treatment) prior to and after the cluster among inpatient hematology/oncology patients. The grey bars indicate the total number of unique inpatients during each month admitted to inpatient hematology/oncology units. Blue bars indicate the number of patients on posaconazole during these periods. The yellow arrow indicates the starting point for post-cluster interventions. Comparing Sept 2013 through August 2014 and Sept 2014 through August 2015, use of posaconazole significantly increased (90/3614 [2.5%] vs. 575/3973 [14.5%], p < 0.001)Back to article page